Patent · US Active

Methods for diagnosis of type 1 diabetes

US11567088B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignees

Inventors

Joshua LaBaer · Chandler, US
Ji Qiu · Chandler, US
Xiaofang Bian · Mesa, US
Desmond A. Schatz · Gainesville, US
Clive H. Wasserfall · Gainesville, US
Mark A. Atkinson · Gainesville, US

Key dates

Filing date	Feb 14, 2020
Grant date	Jan 31, 2023
Priority date	—
Expiry date	Feb 14, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/50
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Type 1 diabetes (T1D) patients make antibodies to self-proteins that are potential biomarkers for early detection and risk prediction. We have identified seventeen antigens as biomarkers for early diagnosis and risk prediction of T1D, including the antigens MLH1, MTIF3, PPIL2, NUP50, TOX4, FIGN, C9orf142, ZNF280D, HES1, QRFPR, CTRC, SNX6, SYTL4, ELA2A, IGRP, PAX6, and HMGN3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.